- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CH-1R Strain
PC Strain
Others
Market segment by Application can be divided into
Gilts
Sows
The key market players for global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market are listed below:
Merck
HIPRA
Sinopharm Animal Health Co., Ltd
Ceva Santé Animale
CAVAC
Bioveta
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Harbin Pharmaceutical Group
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, with price, sales, revenue and global market share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine from 2019 to 2021.
Chapter 3, the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 CH-1R Strain
1.2.3 PC Strain
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Gilts
1.3.3 Sows
1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size & Forecast
1.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value (2016-2026))
1.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume (2016-2026)
1.4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2016-2026) & (US$/Unit)
1.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Capacity Analysis
1.5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Total Production Capacity (2016-2026)
1.5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
1.6.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
1.6.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.1.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 HIPRA
2.2.1 HIPRA Details
2.2.2 HIPRA Major Business
2.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.2.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sinopharm Animal Health Co., Ltd
2.3.1 Sinopharm Animal Health Co., Ltd Details
2.3.2 Sinopharm Animal Health Co., Ltd Major Business
2.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.3.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Ceva Santé Animale
2.4.1 Ceva Santé Animale Details
2.4.2 Ceva Santé Animale Major Business
2.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 CAVAC
2.5.1 CAVAC Details
2.5.2 CAVAC Major Business
2.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.5.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Bioveta
2.6.1 Bioveta Details
2.6.2 Bioveta Major Business
2.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.6.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Jinyu Bio-Technology
2.7.1 Jinyu Bio-Technology Details
2.7.2 Jinyu Bio-Technology Major Business
2.7.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.7.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Zoetis
2.8.1 Zoetis Details
2.8.2 Zoetis Major Business
2.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.9.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Harbin Pharmaceutical Group
2.10.1 Harbin Pharmaceutical Group Details
2.10.2 Harbin Pharmaceutical Group Major Business
2.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
2.10.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturer
3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer Market Share
3.4.2 Top 6 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer Market Share
3.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region
4.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2016-2026)
4.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026)
4.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026)
4.4 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026)
4.5 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026)
4.6 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Type (2016-2026)
5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2016-2026)
5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Application (2016-2026)
6.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2016-2026)
6.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2026)
7.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2026)
7.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
7.3.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2026)
8.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2026)
8.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
8.3.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region
9.3.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2026)
10.2 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2026)
10.3 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
10.3.1 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
11.3.1 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Distributors
12.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 6. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. HIPRA Basic Information, Manufacturing Base and Competitors
Table 8. HIPRA Major Business
Table 9. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 10. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sinopharm Animal Health Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 12. Sinopharm Animal Health Co., Ltd Major Business
Table 13. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 14. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table 16. Ceva Santé Animale Major Business
Table 17. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 18. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. CAVAC Basic Information, Manufacturing Base and Competitors
Table 20. CAVAC Major Business
Table 21. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 22. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bioveta Basic Information, Manufacturing Base and Competitors
Table 24. Bioveta Major Business
Table 25. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 26. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 28. Jinyu Bio-Technology Major Business
Table 29. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 30. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Zoetis Basic Information, Manufacturing Base and Competitors
Table 32. Zoetis Major Business
Table 33. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 34. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 36. Boehringer Ingelheim Major Business
Table 37. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 38. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 40. Harbin Pharmaceutical Group Major Business
Table 41. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product and Services
Table 42. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Site of Key Manufacturer
Table 48. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine New Entrant and Capacity Expansion Plans
Table 49. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Mergers & Acquisitions in the Past Five Years
Table 50. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2016-2021e) & (K Units)
Table 51. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (K Units)
Table 52. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 54. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units)
Table 56. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2016-2021e) & (US$/Unit)
Table 59. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2026) & (US$/Unit)
Table 60. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 61. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units)
Table 62. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 64. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2016-2021e) & (US$/Unit)
Table 65. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2026) & (US$/Unit)
Table 66. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2016-2021e) & (K Units)
Table 67. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units)
Table 68. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 70. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 71. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units)
Table 72. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 73. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units)
Table 74. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2016-2021e) & (K Units)
Table 75. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units)
Table 76. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 79. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units)
Table 80. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 81. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units)
Table 90. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2016-2021e) & (K Units)
Table 91. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units)
Table 92. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 94. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 95. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units)
Table 96. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 97. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Distributors
Table 109. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Typical Customers
List of Figures
Figure 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Picture
Figure 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type in 2020
Figure 3. CH-1R Strain
Figure 4. PC Strain
Figure 5. Others
Figure 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application in 2020
Figure 7. Gilts
Figure 8. Sows
Figure 9. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2016-2026) & (K Units)
Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Capacity (2016-2026) & (K Units)
Figure 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
Figure 16. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
Figure 17. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Trends
Figure 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturer in 2020
Figure 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturer in 2020
Figure 20. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2016-2026)
Figure 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2016-2026)
Figure 25. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026) & (USD Million)
Figure 26. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2016-2026) & (USD Million)
Figure 30. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2016-2026)
Figure 31. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2016-2026)
Figure 32. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2016-2026)
Figure 34. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2016-2026)
Figure 35. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2016-2026)
Figure 37. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2016-2026)
Figure 38. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2016-2026)
Figure 39. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2016-2026)
Figure 40. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2016-2026)
Figure 44. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2016-2026)
Figure 45. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2016-2026)
Figure 46. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2016-2026)
Figure 47. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2016-2026)
Figure 56. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2016-2026)
Figure 63. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2016-2026)
Figure 64. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2016-2026)
Figure 65. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2016-2026)
Figure 66. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2016-2026)
Figure 72. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
